Literature DB >> 12959512

Timing is everything: executive functions in children exposed to elevated levels of phenylalanine.

Kevin M Antshel1, Susan E Waisbren.   

Abstract

This study addresses how the timing of a known biological insult affects the developmental progression of executive functions. The sample consisted of children exposed to elevated levels of phenylalanine, either postnatally, as in phenylketonuria (PKU; n = 46), or prenatally, as in maternal PKU (n = 15). Nonhyperphenylanemic siblings of children with PKU (n = 18) served as controls. Results indicated that elevated levels of phenylalanine are toxic to the neurological systems that manage executive functions and cognitive tempo. This toxicity is dose dependent, with higher levels of phenylalanine being more detrimental. Executive function difficulties noted in PKU are consistent with attention deficit hyperactivity disorder (ADHD)-inattentive type, whereas maternal PKU offspring had executive function difficulties consistent with ADHD-combined type.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12959512     DOI: 10.1037/0894-4105.17.3.458

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  10 in total

1.  Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.

Authors:  Susan E Waisbren; Yuval Landau; Jenna Wilson; Jerry Vockley
Journal:  Dev Disabil Res Rev       Date:  2013

2.  Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria.

Authors:  Krista S Viau; Heidi J Wengreen; Sharon L Ernst; Nancy L Cantor; Larissa V Furtado; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

3.  Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.

Authors:  Rachael Sharman; Karen A Sullivan; Ross McD Young; James J McGill
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

4.  Associations between performance on the Rey-Osterrieth Complex Figure and regional brain volumes in children with and without velocardiofacial syndrome.

Authors:  Kevin M Antshel; Jena Peebles; Nuria AbdulSabur; Anne Marie Higgins; Nancy Roizen; Robert Shprintzen; Wanda P Fremont; Robert Nastasi; Wendy R Kates
Journal:  Dev Neuropsychol       Date:  2008       Impact factor: 2.253

Review 5.  Attention-deficit hyperactivity disorder in girls: epidemiology and management.

Authors:  Jud Staller; Stephen V Faraone
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria.

Authors:  Alexandre Rebuffat; Cary O Harding; Zhaobing Ding; Beat Thöny
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

7.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

8.  Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.

Authors:  Vivienne A Russell; Robert D Oades; Rosemary Tannock; Peter R Killeen; Judith G Auerbach; Espen B Johansen; Terje Sagvolden
Journal:  Behav Brain Funct       Date:  2006-08-23       Impact factor: 3.759

9.  Attention Deficit Disorder with Hyperactivity Symptoms in Early-Treated Phenylketonuria Patients.

Authors:  Mayara Thays Beckhauser; Marcella Beghini Mendes Vieira; Betine Moehlecke Iser; Gisele Rozone DE Luca; Marcelo Rodrigues Masruha; Jaime Lin; Emilio Luiz Streck
Journal:  Iran J Child Neurol       Date:  2020

10.  Behavioral and Emotional Problems in Early-Treated Brazilian Children and Adolescents with Phenylketonuria.

Authors:  Eduardo Vieira Neto; Heber de Souza Maia Filho; Claudia Braga Monteiro; Lilian de Mattos Carvalho; Thuane Silva da Cruz; Belisia Vasconcelos de Barros; Marcia Gonçalves Ribeiro
Journal:  Med Sci Monit       Date:  2018-10-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.